All AbMole products are for research use only, cannot be used for human consumption.
HU-308 is a potent, selective agonist of the cannabinoid receptor CB2, with Ki values of 22.7nM and >10 mM for CB2 and CB1, respectively. HU-308 has anti-inflammatory and neuroprotective properties. HU-308 reduces liver damage in a hepatic ischemia/reperfusion injury model.
| Molecular Weight | 414.62 |
| Formula | C27H42O3 |
| CAS Number | 256934-39-1 |
| Solubility (25°C) | DMSO 2 mg/mL |
| Storage | -20°C, sealed |
| Related Cannabinoid Products |
|---|
| UCM707
UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of Anandamide. |
| SCH 336
SCH 336 is a potent, selective, inverse and orally active CB2 agonist. |
| JTE-907
JTE-907 is a highly selective, orally active CB2 receptor inverse agonist and exerts anti-inflammatory effects in vivo. |
| LEI-101
LEI-101 is a potent, selective, and orally bioavailable cannabinoid CB2 receptor agonist, with a pEC50 of 8 for hCB2, and a pKi of less than 4 for hERG. |
| AEF0117
AEF0117 is a signaling-specific inhibitor of the cannabinoid receptor 1 (CB1-SSi). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
